Researching Circulate Health?
Unlock the full Circulate Health story — free for 7 days, no credit card
Start a free Fundz Strategic trial: get everything on Circulate Health — investors, amounts, verified contacts — plus thousands more new contracts and a daily AI lead briefing built around your ICP. No credit card.
Everything on Circulate Health
Investors, amounts, the people behind it — and verified contacts.
Thousands more like it
Search every new contracts and more — filtered to your market.
AI leads for your ICP
A daily briefing of companies matching exactly who you sell to.
No credit card Full Strategic access for 7 days No commitment
Circulate Health and Reborne announce exclusive partnership to introduce therapeutic plasma exchange in the UK.
Jun 25, 2026•6 days ago
Contract Type
partnership
SeattleBiotechnologyHealth Carehospital & health careDescription
Circulate Health has partnered with Reborne to bring its advanced therapeutic plasma exchange procedures to the UK. This agreement is notable as it marks Circulate Health's first partnership in Europe and establishes Reborne as the first UK hospital to offer these innovative medical procedures.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months